{"DataElement":{"publicId":"6689326","version":"1","preferredName":"Lung Precancerous Condition Histopathologic Examination Other Specify","preferredDefinition":"A result different than the one(s) previously specified describing the result of a precancerous lung tissue histopathologic examination.","longName":"LUNG_PRE_CA_HISTOPATH_OTHR_SP","context":"MCL","contextVersion":"1","DataElementConcept":{"publicId":"6687917","version":"1","preferredName":"Lung Precancerous Condition Histopathologic Examination","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border._Pathological processes that tend eventually to become malignant. (From Dorland, 27th ed)_The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.","longName":"2399007v1.0:6753443v1.0","context":"MCL","contextVersion":"1","ObjectClass":{"publicId":"2399007","version":"1","preferredName":"Lung","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.","longName":"C12468","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF1C626B-A28E-1F9E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-29","endDate":null,"createdBy":"HARDINGR","dateCreated":"2005-08-29","modifiedBy":"ONEDATA","dateModified":"2005-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6753443","version":"1","preferredName":"Precancerous Condition Histopathologic Examination","preferredDefinition":"Pathological processes that tend eventually to become malignant. (From Dorland, 27th ed):The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.","longName":"C3341:C18190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Precancerous Condition","conceptCode":"C3341","definition":"A pathological process with signs indicating it may become cancerous.  Representative examples include leukoplakia, dysplastic nevus, actinic keratosis, xeroderma pigmentosum, and intraepithelial neoplasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histopathologic Examination","conceptCode":"C18190","definition":"The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8863001C-C2AC-5839-E053-F662850AD2A9","latestVersionIndicator":"Yes","beginDate":"2019-05-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-08","modifiedBy":"ONEDATA","dateModified":"2019-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"85F78071-4FC8-462C-E053-F662850AD9B5","latestVersionIndicator":"Yes","beginDate":"2019-04-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-07","modifiedBy":"KNABLEJ","dateModified":"2020-02-06","changeDescription":"4/25/19 jk released/qualified per review by Sarah M. 4/7/19 jk created for MCL PCA Lung.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2666713","version":"2","preferredName":"Other Specify","preferredDefinition":"Different than the one(s) previously specified or mentioned._Be specific about something; define clearly.","longName":"OTH_SPEC","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208051","version":"1","preferredName":"Other Specify","preferredDefinition":"Not otherwise specified.:Specify; be specific about something; define clearly.","longName":"C17649:C25685","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3B5E-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"132D4785-528E-5337-E050-BB89AD433CA8","latestVersionIndicator":"Yes","beginDate":"2015-04-07","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"HARTLEYG","dateModified":"2018-06-06","changeDescription":"7/19/17 jk transferred context and added registration status, CSI per Round 5 finalization task. 4/28/15 released. jc  4/7/15 VD versioned per COG WG: inc to 100 char, remove min limit, chg concept domain to assessment result. jc 1/25/13 added ACRIN Old caBIG CSI.  3/21/12 - changed origin from IVI to ACRIN.  3/5/08 - released for UoWASH FES CRF.   7/23/07-created for ACRIN PET CDEs","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506111","version":"1","longName":"Lung","context":"MCL","ClassificationSchemeItems":[{"publicId":"5858018","version":"1","longName":"Lung-UCLA","context":"MCL"},{"publicId":"7781146","version":"1","longName":"Lung PCA Pilot","context":"MCL"},{"publicId":"5858017","version":"1","longName":"Lung Core","context":"MCL"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001792","version":"1","longName":"Lung PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"histopathology_precancer_type_other","type":"MCL Alt Name","context":"MCL"}],"ReferenceDocuments":[{"name":"Other Specify","type":"Preferred Question Text","description":"Other Specify","url":null,"context":"MCL"},{"name":"MCL-PCA-Lung-1","type":"Alternate Question Text","description":"Histopathology precancer type, Other","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"lung_v0_template-1.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"862379F9-D386-66A3-E053-F662850A85E4","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-09","modifiedBy":"COLBERTM","dateModified":"2021-09-13","changeDescription":"9/2/21 mr Added AQT, alt name, ref doc to match MCL DD.  4/25/19 jk released/qualified per review by Sarah M. 4/9/19 jk created for PCA Lung.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}